• HOME
  • ABOUT
  • COMPANY

peptide discovery

2024.08.13 01:10
Advancing Drug Discovery with KPDS™: A Comprehensive Peptide Platform
 In the rapidly evolving field of drug discovery, innovation and precision are paramount. Our company, through its proprietary KPDS™ platform (KS-V Peptide Discovery Services Platform), stands at the forefront of peptide drug discovery. The KPDS™ platform is internationally recognized for its advanced capabilities in peptid...
2024.05.08 01:38
Exploring Peptide Discovery: Unveiling Nature’s Molecular Gems
Introduction: Peptides, as nature’s molecular artisans, offer a treasure trove of therapeutic potential, from combating diseases to advancing biotechnological applications. The pursuit of discovering novel peptides is a captivating journey into the intricate world of molecular design and function. This article delves into the st...
2024.01.19 01:43
Novel Drug Approvals for 2023
In 2023, the U.S. Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) hit a significant milestone, approving 55 new drugs, an increase of nearly 50% from last year and second only to the all-time high of 2018 . This number highlights the innovative trend in the pharmaceutical field and demonstrate...

longpeptide

KS-V Peptide has provided peptide services to over 1,000 academic clients and 100 industrial clients from more than 30 countries. We are committed to promoting innovation to support drug research and

記事一覧

Copyright © 2025 longpeptide.

Powered byAmebaOwnd無料でホームページをつくろう